Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00761176 · ClinicalTrials.gov registry record · NA
A Pilot Study of the Provant Therapy System in Subjects With Diabetic Foot Ulcers
A NA study, sponsored by Regenesis Biomedical.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT00761176: Clinical Trial NA study, sponsored by Regenesis Biomedical.
NCT00761176 is a NA study that was terminated before completion, run by Regenesis Biomedical. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00761176, a NA study, was terminated before completion, sponsored by Regenesis Biomedical.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The objective of this study is to compare the reduction in wound surface areas between patients with diabetic ulcers utilizing Provant's pulsed radio frequency energy therapy (PRFE) as an adjunct to standardized basic wound care to those utilizing standardized basic wound care alone.
Interventions
- DEVICE The Provant Therapy System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2008-07 |
| Est. Completion | 2011-03 |
| Phase | NA |
Why NCT00761176 stopped before completion
NCT00761176 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which The Provant Therapy System is the first listed.
NCT00761176 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00761176 about?
NCT00761176 is a clinical study titled "A Pilot Study of the Provant Therapy System in Subjects With Diabetic Foot Ulcers". The objective of this study is to compare the reduction in wound surface areas between patients with diabetic ulcers utilizing Provant's pulsed radio frequency energy therapy (PRFE) as an adjunct to standardized basic wound care to those utilizing standardized basic wound care alone.
What is the current status of trial NCT00761176?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2008-07. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00761176?
The interventions under investigation include: The Provant Therapy System (DEVICE).
Who is sponsoring clinical trial NCT00761176?
This trial is sponsored by Regenesis Biomedical, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00761176's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia